Denise Faltischek

Tilray Joins German Cannabis Fiesta With First Locally Grown Strains

Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals

Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia

Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals

Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia

Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds

Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More

Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds

Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More

Huge Benefits For Medical Marijuana Patients, Opportunities For Innovation & Research – Industry Vets Weigh In On Germany's Cannabis Reform

Tilray Medical Applauds German Bundestag And Landmark Passage Of Medical Cannabis Act In Germany

Denise Faltischek Recent News

Tilray Medical Joins Fight Against Deadly Brain Tumors, Here's What's Happening

On Monday, Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, which is a seve

Italians To Enjoy Medical Marijuana Offerings From One Of The Biggest Cannabis Companies In The World

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced that its medical cannabis division, Tilray Medical and FL Group, the company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new medical cannabis c

Tilray Medical Enters Into Export And Distribution Partnership With Cansativa Group

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced that its medical cannabis division, Tilray Medical, has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group.

Tilray Medical Relaunches Cannabis Oral Solution Across Ireland With Reimbursement Approval

Canadian cannabis giant, Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP).

Tilray's Medical Cannabis Oral Solution Approved For Pharmaceutical Distribution In Italy

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s

Tilray Initiates Roundtable With German Regulators On Adult-Use Cannabis Legalization In Germany

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany.

Tilray Follows Curaleaf, Gets Approval To Enter Medical Cannabis Market In Poland

Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland expanding its product offering and distribution across pharmacies in Europe.

Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.

Tilray Poised To Conquer Malta's Medical Marijuana Market - Launches First Medical Cannabis Oil

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) confrimed Thursday that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta.

Tilray Launches Medical Cannabis Products In Malta

Tilray Brands, Inc.

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers.

Tilray's First Harvest And Distribution Of Medical Cannabis In Germany Successfully Completed

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) finalized its first harvest of medical cannabis grown in Germany via its German subsidiary Aphria RX GmbH.